“Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources” plus 9 more Reuters: Health News
“Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources” plus 9 more Reuters: Health News |
- Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources
- Perrigo to review options for multiple sclerosis drug royalties
- Soda taxes spread after votes in four U.S. cities
- J&J vaccine plus Gilead immune booster shows promise as HIV fighter
- Torn lab suit used in Canada Ebola experiment faces review
- Novartis, Pfizer cut prices to win UK approval for cancer drugs
- Haiti launches massive cholera vaccination drive but worries remain
- Female researchers underrepresented, but collaborate widely
- Mylan working to finalize EpiPen Medicaid settlement: CFO
- Smartphone screen time tied to lower sleep quality
| Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources Posted: 09 Nov 2016 03:46 PM PST (Reuters) - U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. |
| Perrigo to review options for multiple sclerosis drug royalties Posted: 09 Nov 2016 11:41 PM PST (Reuters) - Perrigo Company Plc, a maker of generic and over-the-counter drugs, said it will review strategic alternatives for the rights to the royalties from sales of its multiple sclerosis drug. |
| Soda taxes spread after votes in four U.S. cities Posted: 09 Nov 2016 09:21 AM PST (Reuters) - Three California cities voted for a tax on sugar-sweetened beverages and another in Colorado was likely to follow suit, unofficial election results showed on Wednesday, as local governments' push to cut soda consumption to stem obesity gathered speed. |
| J&J vaccine plus Gilead immune booster shows promise as HIV fighter Posted: 09 Nov 2016 12:06 PM PST CHICAGO (Reuters) - An experimental HIV vaccine from Johnson & Johnson combined with an immune system booster from Gilead Sciences Inc showed promise at keeping the virus at bay in monkeys even after treatments had stopped, marking yet another step toward the development of a so-called functional cure for HIV. |
| Torn lab suit used in Canada Ebola experiment faces review Posted: 09 Nov 2016 02:04 PM PST WINNIPEG, Manitoba (Reuters) - The Canadian government will review the use of a suit designed to shield laboratory workers from dangers such as the Ebola virus after an employee found a tear following an experiment, the lab's director said on Wednesday. |
| Novartis, Pfizer cut prices to win UK approval for cancer drugs Posted: 09 Nov 2016 04:03 PM PST LONDON (Reuters) - Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain's National Health Service after offering bigger price discounts. |
| Haiti launches massive cholera vaccination drive but worries remain Posted: 09 Nov 2016 12:33 PM PST LES CAYES, Haiti (Reuters) - Haiti has launched a massive cholera vaccination campaign to battle a flare-up after Hurricane Matthew, but concerns remain about the capacity for longer-term improvements to water and sanitation infrastructure needed to eradicate the disease. |
| Female researchers underrepresented, but collaborate widely Posted: 09 Nov 2016 01:30 PM PST (Reuters Health) - Women researchers in science, technology, engineering and mathematics (STEM) departments tend to have a wider range of collaborators than men, but are still significantly underrepresented, especially in genomics, according to a new study. |
| Mylan working to finalize EpiPen Medicaid settlement: CFO Posted: 09 Nov 2016 03:45 PM PST (Reuters) - Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss. |
| Smartphone screen time tied to lower sleep quality Posted: 09 Nov 2016 12:10 PM PST (Reuters Health) - Using smartphones to measure how much time people spend looking at those phones confirms that more screentime is tied to poorer sleep, researchers say. |
| You are subscribed to email updates from Reuters: Health News. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Lexo edhe:
